We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
State Street
STT
$50.9B
| $16.9M | 0.04% |
230,865
+18,006
| +8% | +$1.29M |
|
427
Revvity
RVTY
$15.6B
| $16.8M | 0.04% |
141,766
-7,191
| -5% | -$884K |
|
428
MarketAxess Holdings
MKTX
$5.75B
| $16.8M | 0.04% |
64,251
-950
| -1% | -$283K |
|
429
EXL Service
EXLS
$5.5B
| $16.8M | 0.04% |
555,715
+18,065
| +3% | +$570K |
|
430
Littelfuse
LFUS
$10B
| $16.6M | 0.04% |
57,105
+14,239
| +33% | +$3.73M |
|
431
Terex
TEX
$6.67B
| $16.6M | 0.04% |
277,200
-42,879
| -13% | -$2.13M |
|
432
Revolve Group
RVLV
$1.47B
| $16.5M | 0.04% |
1,003,558
+229,258
| +30% | +$4.27M |
|
433
Starbucks
SBUX
$110B
| $16.4M | 0.04% |
165,901
-45,576
| -22% | -$4.73M |
|
434
nVent Electric
NVT
$23.8B
| $16.4M | 0.04% |
317,932
-16,991
| -5% | -$754K |
|
435
Trip.com Group
TCOM
$24.7B
| $16.4M | 0.04% |
468,568
+189,466
| +68% | +$6.59M |
|
436
Pacira BioSciences
PCRX
$960M
| $16.4M | 0.04% |
408,058
+258,394
| +173% | +$10.7M |
|
437
Vericel Corp
VCEL
$2.03B
| $16.3M | 0.04% |
434,205
-20,588
| -5% | -$677K |
|
438
SPS Commerce
SPSC
$2.95B
| $16.2M | 0.04% |
84,114
+14,113
| +20% | +$2.28M |
|
439
Icon
ICLR
$13.3B
| $16.1M | 0.04% |
64,529
-44,682
| -41% | -$9.49M |
|
440
Duolingo
DUOL
$7.2B
| $16.1M | 0.04% |
112,933
+26,141
| +30% | +$3.75M |
|
441
Yext
YEXT
$632M
| $16M | 0.04% |
1,415,710
-71,210
| -5% | -$677K |
|
442
Halliburton
HAL
$29.7B
| $16M | 0.04% |
484,857
+1,565
| +0.3% | +$49.4K |
|
443
Cencora
COR
$61.7B
| $16M | 0.04% |
82,976
+9,341
| +13% | +$1.62M |
|
444
Community Bank
CBU
$3.3B
| $15.9M | 0.04% |
339,995
-16,423
| -5% | -$805K |
|
|
CCRN
445
DELISTED
Cross Country Healthcare
CCRN
| $15.9M | 0.04% |
566,981
+223,914
| +65% | +$5.56M |
|
446
Boise Cascade
BCC
$2.65B
| $15.7M | 0.04% |
174,108
-186,255
| -52% | -$13.6M |
|
447
Clarus
CLAR
$134M
| $15.6M | 0.04% |
1,706,311
+1,431,366
| +521% | +$12.6M |
|
|
NOVA
448
DELISTED
Sunnova Energy
NOVA
| $15.5M | 0.04% |
848,449
-586,038
| -41% | -$9.93M |
|
|
LUCK
449
Lucky Strike Entertainment
LUCK
$748M
| $15.5M | 0.04% |
1,332,482
+115,718
| +10% | +$1.54M |
|
450
Match Group
MTCH
$10.2B
| $15.4M | 0.04% |
367,097
-129,093
| -26% | -$4.72M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.